Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the patented aqueous synthesis method for Cilostazol (CN1257902C). Achieve >99% purity with reduced environmental impact and optimized manufacturing costs.
Patent CN85101840A details a novel stereoselective route for 16-phenoxy prostaglandin trienoic acid derivatives, offering improved crystallinity and supply chain reliability for pharmaceutical manufacturers.
Patent CN114057790B reveals high all-trans vitamin A phosphine salt synthesis. Enables cost reduction in vitamin manufacturing and reliable supply chain stability.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.
Patent CN112409115B discloses a novel aryl silane route for trifluoromethylthio compounds, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114105877A details a green synthesis of Fipronil intermediates using phase transfer catalysis, offering high purity and reduced environmental impact for agrochemical manufacturing.
Patent CN107266283B introduces a novel diacyl peroxide method for Heck reactions. Achieve high-purity pharmaceutical intermediates with reduced costs and scalable supply chains.
Patent CN1902166A reveals a novel route for Tamsulosin HCl using excess achiral reagent and thermal crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN87105804A details a novel route for L-carnitine intermediates, offering cost reduction in pharma manufacturing and reliable supply chain solutions.
Patent CN106699507B details water-based hydrogenation for high-purity alpha-phenylethanol. This green process ensures supply chain reliability and significant cost reduction.
Patent CN101747352B reveals a novel crystallization method for biapenem intermediates using lower alcohols to enhance purity and filtration efficiency for industrial scale-up.
Patent CN107746418A details a novel platinum complex targeting liver cancer with reduced toxicity. Discover synthesis advantages and supply chain reliability for pharmaceutical manufacturing.
Patent CN103641731B reveals a high-yield synthesis route for phenylacetamide derivatives. Discover cost-effective manufacturing and supply chain advantages for agrochemical intermediates.
Patent CN101993398B details a green catalytic hydrogenation method for 1,8-diamino-3,6-naphthalene disulfonic acid, offering high purity and eliminating iron sludge waste for reliable supply.
Patent CN108299482B details a novel nucleophilic route for 18F-BPA, offering higher specific activity and safer processing for PET imaging agents.
Patent CN102617490A reveals a green metalloporphyrin-catalyzed oxidation route for pyrazine-2-carboxylic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101798272A enables high-purity p-aminoanisole via supercritical CO2 hydrogenation, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN101544591B discloses a mild Wittig-Horner route for (E)-substituted styrenes, offering cost-effective API intermediate manufacturing with high purity.